pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 1
INS-1202
Amyotrophic Lateral Sclerosis
$INSM
INSMED Inc
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
INTRALIPID
INTRALIPID (I. V. FAT EMULSION)
no indication
FRESENIUS
INTROVALE
INTROVALE (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)
← prev
page 109 of 271
next →
Pain
89
Neurology
1
no indication
XIROMED
Phase 1
INV-101
Ulcerative Colitis
Innovo Therapeutics Co Ltd
Preclinical
INV-441
Glioblastoma Multiforme (GBM)
InvIOs GmbH
Preclinical
INV-724
Neuroblastoma
Invenra Inc
Phase 2
INV-9956
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ionova Life Science Co Ltd
Phase 1
INVA-8001
Atopic Dermatitis (Atopic Eczema)
Invea Therapeutics Inc
Phase 2
INX-315
Epithelial Ovarian Cancer
Incyclix Bio LLC
Phase 1
IO-202
Chronic Myelomonocytic Leukemia (CMML)
Immune Onc Therapeutics Inc
Preclinical
IO-312
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Immune Onc Therapeutics Inc
IODIXANOL
IODIXANOL
no indication
HENGRUI PHARMA
IOFLUPANE I 123
IOFLUPANE I 123 (IOFLUPANE I-123)
no indication
CURIUM
Phase 2
ION-283
Lafora Disease (Unverricht Disease)
$IONS
IONIS PHARMACEUTICALS INC
Phase 2
ION-356
Pelizaeus-Merzbacher Disease (PMD)
$IONS
IONIS PHARMACEUTICALS INC
IONOSOL MB AND DEXTROSE
IONOSOL MB AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE)
no indication
OTSUKA ICU MEDCL
IOPAMIDOL
IOPAMIDOL
no indication
HAINAN POLY
Phase 2
IOV-2001
Chronic Lymphocytic Leukemia (CLL)
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Phase 2
IOV-4001
Metastatic Melanoma
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Phase 2
IPG-7236
Head And Neck Cancer
Immunophage Biotech Co Ltd
Phase 1
IPH-4502
Breast Cancer
$IPHA
Innate Pharma SA
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
no indication
CIPLA
IPRATROPIUM BROMIDE INHALATION
IPRATROPIUM BROMIDE INHALATION
no indication
ARMSTRONG PHARMS
Preclinical
IR-101C
Coronavirus Disease 2019 (COVID-19)
Immune Response BioPharma Inc
IRBESARTAN AND HYDROCHLOROTHIAZIDE
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)
no indication
Prinston Pharmaceutical Inc
IRINOTECAN HYDROCHLOIDE
IRINOTECAN HYDROCHLOIDE
no indication
GLAND
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
IRON SUCROSE
IRON SUCROSE
no indication
Sandoz Inc
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
